Dysphagia is a common and potentially life-threatening chronic toxicity of radiotherapy (RT) for people with head and neck cancer (HNC). Swallowing therapy is commonly provided to lessen the risk or severity of dysphagia, but best practice is not established. Despite the uncertainty in the literature, speech-language pathologists need to make decisions about when to prescribe interventions and what intervention is the most appropriate.
This talk reviews the current evidence regarding the benefit of behavioural swallowing therapy for patients with HNC and reviews current international efforts to address this treatment dilemma.
Groupes d’âge concernés
- Adulte (18 à 64 ans)
- Personnes âgées (65 ans et plus)
L’accès aux webinaires et aux webémissions d’OAC est un avantage exclusif des membres OAC.